Previous studies have suggested that PU.1 and C/EBPα modulate microglial activation and proliferation during neurodegenerative processes and appear to be upregulated in human AD and prion diseases (Greter and Merad, 2013). This evidence concerns the gene SPI1 and Alzheimer disease.